Preparation containing bacillus subtilis YL13 for antagonizing diseases and/or promoting growth of plants and application of the preparation
A technology of Bacillus subtilis and diseases, applied in the direction of plant growth regulators, plant growth regulators, applications, etc., can solve the problems of few broad-spectrum biocontrol strains, limit the scope of use of strains, and have no significant inhibitory effect, etc., to achieve The effect of low cost, outstanding effect and simple preparation method
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] Embodiment 1, the obtaining process of bacterial strain YL13 of the present invention
[0045] Using ultraviolet rays to mutate the Bacillus subtilis Y13 with the preservation number CCTCC NO:M 208264, using Dalbergia anthracnose as the pathogenic bacteria, the best mutagenic strain Uv-8 was obtained by screening, and the bacteriostatic rate was above 80.75%; -Nitrosoguanidine compound mutagenesis, screened and obtained the best mutant strain NTG1-8, the bacteriostatic rate reached 86.47%, which was 12.79% higher than the original strain Y13, and it was renamed as YL13.
[0046]
[0047]
[0048] Bacteriostatic rate is control effect
[0049] Table 1 Ultraviolet Mutation Shake Flask Re-screening Results
[0050]
[0051] Table 2 Compound mutagenesis re-screening results
[0052]
Embodiment 2
[0053] Embodiment 2: the bacteriostasis comparison of mutagenic strain YL13 and starting strain Y13
[0054] Table 3 Inhibitory effect of mutagenic strain Y13 on plant pathogenic fungi
[0055]
[0056] Inhibitory effect of table 4 mutagenic strain YL13 on phytopathogenic fungi
[0057]
[0058]
Embodiment 3
[0059] Embodiment 3: the preparation of biocontrol agent of the present invention
[0060] The carriers and auxiliaries in Table 5 were specifically tested for their influence on the growth of YL13 by plate counting method.
[0061] Table 5 Effects of different carriers and additives on the growth of YL13
[0062]
[0063] Original drug: YL13 fermentation broth
[0064] (1) Preparation of the initial dosage form: the optimal carrier bentonite and the original drug (thalline concentration 8.0×10 10 cfu / mL) according to the mass ratio of material to liquid of 7:1, mixed evenly, dried in an oven at 50±1°C, and crushed into powder.
[0065] (2) Screening of wetting agents: wettability is one of the important indicators to measure the quality of water-dispersible granules, because sodium butyl naphthalene sulfonate has a slightly stronger inhibition on YL13 than tea dry powder, but its wetting The time is shorter, so sodium butyl naphthalene sulfonate is preferred. Using the...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com